Citation: | Ma Yong-duo, Wang Cong, Li Hai-xiang, Wu Huan. Detection of urinary levels of matrix metalloproteinase-7 and tumor necrosis factor-like weak inducer of apoptosis in patients with IgA nephropathy and values in predicting disease progression[J]. Journal of Clinical Nephrology, 2022, 22(5): 382-387. DOI: 10.3969/j.issn.1671-2390.2022.05.006 |
[1] |
Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy:an interesting autoimmune kidney disease[J]. Am J Med Sci, 2021, 361(2):176-194. DOI:10. 1016/j. amjms. 2020. 10. 003.
|
[2] |
Zhang J, Ren PP, Wang YC, et al. Serum matrix metalloproteinase-7 level is associated with fibrosis and renal survival in patients with IgA nephropathy[J]. Kidney Blood Press Res, 2017, 42(3):541-552. DOI:10. 1159/000477132.
|
[3] |
Poveda J, Vázquez-Sánchez S, Sanz AB, et al. TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome[J]. J Pathol,2021,254(1):5-19. DOI:10. 1002/path. 5631.
|
[4] |
谢燕, 陈源汉, 梁馨苓, 等. IgA肾病预后评估模型的研究进展[J]. 中华肾脏病杂志, 2021, 37(3):234-238. DOI:10. 3760/cma. j. cn441217-20200915-00037. Xie Y, Chen YH, Liang XL, et al. Research progress on prognostic evaluation models of IgA nephropathy[J]. Chin J Nephrol, 2021, 37(3):234-238. DOI:10. 3760/cma. j. cn441217-20200915-00037:
|
[5] |
Miyabe Y, Karasawa K, Akiyama K, et al. Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy[J]. Sci Rep, 2021, 11(1):3584.DOI:10. 1038/s41598-021-82967-x.
|
[6] |
Alexander S,Varughese S,Franklin R,et al. Epidemiology, baseline characteristics and risk of progression in the first SouthAsian prospective longitudinal observational IgA nephropathy cohort[J]. Kidney Int Rep, 2020, 6(2):414-428. DOI:10. 1016/j. ekir. 2020. 11. 026.
|
[7] |
Liu Z, Tan RJ, Liu YH. The many faces of matrix metalloproteinase-7 in kidney diseases[J]. Biomolecules, 2020, 10(6):960. DOI:10. 3390/biom10060960.
|
[8] |
Bernardi S,Voltan R,Rimondi E,et al. TRAIL,OPG,and TWEAK in kidney disease:biomarkers or therapeutic targets?[J]. Clin Sci(Lond), 2019, 133(10):1145-1166. DOI:10. 1042/CS20181116.
|
[9] |
Salem MN, Taha HA, Abd El-Fattah El-Feqi M, et al. Urinary TNF-like weak inducer of apoptosis(TWEAK) as a biomarker of lupus nephritis[J]. Z Rheumatol, 2018, 77(1):71-77. DOI:10. 1007/s00393-016-0184-1.
|
[10] |
刘其锋, 李莎莎. TWEAK与肾脏疾病研究进展[J]. 国际泌尿系统杂志, 2016, 36(3):472-475. DOI:10. 3760/cma. j. issn. 1673-4416. 2016. 03. 048.
Liu QF, Li SS. Research progress of tweak and kidney disease[J]. International Journal of Urology, 2016, 36(3):472-475. DOI:10. 3760/cma. j. issn. 1673-4416. 2016. 03. 048.
|
[11] |
Yeter HH, Gonul I, Guz G, et al. Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival[J]. Rom J Intern Med, 2020, 58(4):209-218. DOI:10. 2478/rjim-2020-0025.
|
[12] |
Bobart SA, Alexander MP, Shawwa K, et al. The association of microhematuria with mesangial hypercellularity,endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy[J]. Nephrol Dial Transplant, 2019, 36(5):840-847. DOI:10. 1093/ndt/gfz267.
|
[13] |
Han X, Xiao Y, Tang Y, et al. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome[J]. Clin Exp Med, 2019, 19(4):479-486. DOI:10. 1007/s10238-019-00580-9.
|
[14] |
Wang GB, Wu LL, Su HJ, et al. Association of urinary matrix metalloproteinase 7 levels with incident renal flare in lupus nephritis[J]. Arthritis Rheumatol,2021,73(2):265-275. DOI:10. 1002/art. 41506.
|
[15] |
Zhou D, Tian Y, Sun L, et al. Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis[J]. J Am Soc Nephrol,2017,28(2):598-611. DOI:10. 1681/ASN. 2016030354.
|
[16] |
Kim JS, Jeong KH. Clinical significance of urinary tumor necrosis factor-like weak inducer of apoptosis(TWEAK) in immunoglobulin A nephropathy[J]. Clin Nephrol, 2020, 93(2):99-105. DOI:10. 5414/CN109821.
|
[17] |
Yang XB, Ou J, Zhang H, et al. Urinary matrix metalloproteinase 7 and prediction of IgA nephropathy progression[J]. Am J Kidney Dis, 2020, 75(3):384-393. DOI:10. 1053/j. ajkd. 2019. 07. 018.
|